412 related articles for article (PubMed ID: 16420307)
1. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
3. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
4. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
5. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
6. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
Sengul D; Sengul I; Astarci MH; Ustun H; Mocan G
Pol J Pathol; 2010; 61(3):140-6. PubMed ID: 21225496
[TBL] [Abstract][Full Text] [Related]
7. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
Kirchmann TT; Prieto VG; Smoller BR
Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2, CD34 and CD10 expression in basaloid follicular hamartoma, vellus hair hamartoma and neurofollicular hamartoma demonstrate full follicular differentiation.
Ramos-Ceballos FI; Pashaei S; Kincannon JM; Morgan MB; Smoller BR
J Cutan Pathol; 2008 May; 35(5):477-83. PubMed ID: 18399809
[TBL] [Abstract][Full Text] [Related]
10. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
11. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Wagoner J; Keehn C; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
14. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma frequently shows histologic features of basal cell carcinoma: a study of 30 cases.
Ball NJ; Tanhuanco-Kho G
J Cutan Pathol; 2007 Aug; 34(8):612-9. PubMed ID: 17640231
[TBL] [Abstract][Full Text] [Related]
16. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
Stashower ME; Smith K; Corbett D; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
18. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
19. CD10 expression helps to differentiate basal cell carcinoma from trichoepithelioma.
Heidarpour M; Rajabi P; Sajadi F
J Res Med Sci; 2011 Jul; 16(7):938-44. PubMed ID: 22279463
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
